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Cigarette and tobacco use is common among ED patients from lower socioeconomic 
backgrounds. Our goal in this study was to conduct moderation and mediation analysis to 
evaluate the effectiveness of an enhanced smoking cessation intervention involving enhanced 
care as compared to standard care for adult smokers in the ED. Our study is a secondary analysis 
of a two-arm randomized clinical trial conducted by Dr. Bernstein, which involved two 
intervention arms; one with enhanced care where the subjects received a motivational interview 
by a trained research assistant, 6 weeks of nicotine replacement therapy (NRT) initiated in the 
ED, a faxed referral to the state smokers’ quitline, a booster call, and a brochure. The subjects in 
control arm subjects received the brochure, which provided quitline information. We used 
mediation analysis to assess the treatment effects of the mediators; NRT use and Quitline calls 
and moderation analysis to evaluate the effect modification or interaction of the moderators; 
baseline nicotine dependency and craving with the treatment. The outcomes were 7-day 
abstinence and number of cigarettes smoked per day at three months. We found significant 
mediation effects with the NRT use on both the outcomes. However, the speaking to a quitline 
counselor had only marginal mediation effects.  We could not detect any interaction or effect 
modification with either of the two moderators on 7-day abstinence and no. of cigarettes smoked 
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Background and Rationale: 
Cigarette smoking and tobacco use is a global epidemic affecting about 1 billion people 
worldwide and killing 6 million people per year (1). In the United States, one of the leading 
causes of preventable deaths and related illnesses is cigarette use. According to U.S. Department 
of Health and Human Services, more than 16 million Americans are currently living with a 
disease attributable to smoking (2).  In 2013, 17.8% (42.1 million) of all American adults aged 
18 and above smoked and more than 480,000 died from smoking-related illnesses. The total 
economic cost of smoking in the United States is more than $300 billion a year (3, 4).  
The majority of smokers in the United States come from lower socioeconomic 
backgrounds as compared to other populations. Poverty status, education and race/ethnicity 
usually determine smoking behaviors in the United States. There is a wide gap between 
socioeconomic status (SES) groups with respect to the use of tobacco products. Smoking 
prevalence remains highest among those who have less than a high school education (28.4%), 
those with no health insurance (28.6%), and those living below the federal poverty level (27.7%) 
(5). To address these growing disparities, public policy efforts have been directed in order to 
increase state Medicaid insurance coverage for evidence-based tobacco cessation treatments (6). 
Currently, all the 50 states and the District of Columbia offer insurance coverage for tobacco 
cessation treatment to Medicaid recipients (7), but the degree of coverage for services is different 
in each state and these services are typically underutilized (8). Interventions delivered in health 
care settings by physicians have the potential to reach a wide range of smokers, considering that 
more than 70% of smokers see their physician each year. The Emergency Department (ED) 
presents a unique opportunity for screening, intervention and referral for treatment, as these low 
income populations commonly receive care in hospital emergency departments (ED), either for 
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medical consequences of smoking or for comorbid medical and psychiatric conditions because 
they often have limited access to primary care providers, who tend to undertreat tobacco use 
(9,10, 11). Also, there is a greater prevalence of smoking in ED patients than in the general 
population (12).  
Tobacco control efforts have been taking place in ED settings for many years and a 
recent meta-analysis of 7 ED studies containing 1,986 subjects found enhanced abstinence at one 
month, with the odds for tobacco abstinence in the intervention arm (enhanced care; brochure, 
motivational interview and nicotine patches) of 1.47 (95% CI 1.06-2.06), compared to controls 
(usual care; just brochure) (13). Our study is based on Dr. Steven L Bernstein’s randomized 
clinical trial where they studied the efficacy of an intervention incorporating Screening, Brief 
Intervention, and Referral to Treatment with nicotine replacement therapy (SBIRT + NRT) and 
quitline referral for adult smokers in an ED. In the study, the intervention subjects received a 
motivational interview by a trained research assistant, 6 weeks of nicotine patches and gum 
initiated in the ED, a faxed referral to the state smokers’ quitline, a booster call, and a brochure. 
The controls received the brochure, which provided quitline information. The primary outcome 
was biochemically confirmed tobacco abstinence at three months. The study showed that the 
prevalence of biochemically confirmed abstinence was 12.2% (47/386) in the intervention arm 
vs. 4.9% (19/388) in the control arm, for a difference in quit rates of 7.3% (95% CI 3.2%, 
11.5%).  In multivariable logistic modeling controlling for age, sex, and race/ethnicity, study 
subjects remained more likely to be abstinent than controls (OR 2.72, 95% CI 1.55, 4.75). 
The study utilized a multicomponent intervention model, so we wanted to determine which of 
its individual components were responsible for any improvement compared to the control group. 
Therefore, we planned to conduct a series of mediator analyses to observe the effects of these 
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individual mechanisms. These results will be helpful in refining future the intervention for better 
outcomes. A mediator is a variable that helps in identifying the mechanism or process that 
underlies an observed relationship between an independent variable and a dependent variable. 
We also planned to examine a few moderator analyses to determine the effectiveness of the 
intervention in different subgroups of smokers. A moderator variable is a variable that affects the 
direction and/or strength of the relation between an independent variable and a dependent 
variable Past studies have shown that adherence with nicotine replacement therapy is associated 
with both short-term (as short as 1-week) and long-term (6 months) smoking cessation treatment 
outcome (14,15). We hypothesize that since the SBIRT + NRT intervention increases cessation 
outcomes, NRT adherence is acting as a mediator between the treatment and outcome, hence the 
participants may be more likely to report appropriate adherence with their NRT and 
consequently better smoking cessation outcomes. Therefore, we planned to assess adherence 
with NRT as a mediator. Since the intervention arm incorporated Quitline; we also hypothesized 
that Quitline use will mediate the relationship between the intervention and smoking cessation 
outcome, thereby improving the quitting rates. Hence, we plan to test Quitline use as a mediator. 
Dr. Bernstein’s trial has hypothesized that the tobacco intervention may be more efficacious for 
less nicotine-dependent participants. So, we wanted to examine whether baseline level of 
nicotine dependency moderates the effect of treatment on the cessation outcome. In addition to 
nicotine dependency, we hypothesize whether or not the level of craving (greater or lower), 
measured at the time of discharge from the ED, is likely associated with less smoking and thus 
more abstinence. Thus, we examined if the level of craving will moderate the effect of treatment 






Our study is a secondary data analysis of the study conducted by Dr. Bernstein’s, which 
was a single-hospital 2-arm randomized controlled trial of a multicomponent intervention for 
adult smokers presenting to the ED, with blinded outcome assessment. The intervention arm 
received a brief motivational interview, provision of six weeks of NRT, initiation of NRT in the 
ED, active referral to a smokers’ quitline, a booster phone call 3 days after enrollment, and 
provision of a smoking cessation brochure. The control arm received the brochure alone. The 
study included patients who presented to the adult ED at Yale-New Haven Hospital (YNHH) and 
their eligibility criteria were (1) 18 years or older (2) have smoked >= 100 cigarettes lifetime (3) 
describe themselves as every or someday smokers (4) smoke at least 5 cigarettes/day (5) insured 
by Medicaid or are uninsured, and (6) are able to give written informed consent. Dr. Bernstein’s 
study had a sample size of 778 with 353 in each arm, based on 3-month of follow-up, a quit rate 
in the intervention arm of 20%; in the control arm 12%, and an alpha at 2-sided 0.05 and 80% 
power. Figure 1 illustrates flowchart of the selection and analysis process. 
Outcomes, moderators, and mediators 
Our outcomes are 7-day abstinence (dichotomous) and no. of cigarettes smoked per day 
(continuous) at the 3 month follow-up timepoint. 
We examined two mediators. Our first mediator is Quitline calls, which we divided into 
two groups, have you spoken to a QT counselor (yes/no) or a continuous variable, total quitline 
calls.  Our second mediator is NRT use (continuous), which was evaluated either as total number 
of single NRT used (NRTmax) or total number of combined NRT’s used (NRTcount).  
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For our secondary data analysis, the moderators are baseline nicotine dependency and craving.  
Statistical analysis 
For the moderation analysis, we used SAS version 9.3. To perform moderation, we created an 
interaction term to evaluate the two-way interactions of treatment with the moderators. We used 
logistic regression for the dichotomous outcome and linear regression for the continuous 
outcome. We have ran different models with individual variables in each model.  
For the mediation analysis, we used SPSS Statistics Desktop software version 22.0 with the 
process macro (16) for the continuous outcome and MPlus version 7.2 for the dichotomous 
outcome. To perform mediation, we conducted a series of regression analyses to observe the 
direct and indirect effect of the treatment on the outcomes. In the first step, we regressed the 
exposure to outcome to show that the outcome is associated with the exposure. In the second 
step, we regressed the mediator on the exposure to show that the mediator is associated with 
exposure. In the next step, we regressed the mediator to the outcome but we included treatment 
(intervention) in the model to account for the possibility that both the outcome and mediators are 
caused by exposure. In the last step, we used the previous regression model to test how the effect 
of exposure changes when the mediator is added to the model. We ran different mediation 
models with a mediator in each model. We also ran a model with multiple mediators in the same 
model but the results were not included in this study, since we observed the same mediation 







The 778 subjects in this study were followed from October 2010 to December 2012. 774 (99.5%) 
were alive at 3 months. The table 1 represents the baseline characteristics of study subjects, 
which were comparable between treatment groups. More than half the study subjects were 
nonwhite. Mean daily cigarette consumption was comparable between the two groups. 
Table 1. Baseline patient characteristics. 
Variable Usual Care 
(N = 390) 
Intervention 
(N = 388) 
Age, mean, years  40.2 40.8 
Sex, no. male (%) 201 (51.5%) 170 (43.8%) 















Cigarettes/day, mean, SD 13.7 (SD = 7.4) 13.4 (SD = 8.1) 
 
Below are the frequency tables describing the characteristics of the moderators (baseline nicotine 
dependency and craving) and mediators (have you spoken to QT counsellor, total QT calls, 





Table 2. Characteristics of mediators and moderators. 
Variable Usual Care 
(N = 390) 
Intervention 
(N = 388) 
NRTmax, mean, SD 5.5 (SD = 14.3) 24.1 (SD = 24.5) 
NRTcount, mean, SD 2.75 (SD = 12.9) 32.8 (SD = 39.4) 
Total Quitline Calls, mean, SD 0.31 (SD = 1.07) 0.52 (SD = 1.35) 
Craving, mean, SD 4.64 (SD = 2.16) 4.77 (SD = 2.16) 
Baseline Nicotine Dependency, 
mean, SD 
13.44 (SD = 8.19)  13.71 (SD = 7.47) 
 
Table 3: Did you speak to QT counselor? 
 Frequency Percent 
Valid no 490 62.9 
yes 137 17.6 
Total 627 80.5 
Missing System 152 19.5 
Total 779 100.0 
 
The total no. of cigarettes smoked per day before the trial was, on average, 13 for each group. 
After the treatment, the no. of cigarettes smoked per day went down to, on average, 5 in the 





Table 4: Cigarette smoking before and after  Intervention 
(N = 779) 









Mean 13.44  13.71   5.01 7.62 
Std. 
Deviation 
8.19 7.47 6.00 6.89 
 
For the mediation, the total effect of the treatment on the 7-day abstinence was 0.098. The direct 
and the indirect effects of the mediators are represented in table 5. Of the four mediators, total 
QT calls (p=0.03) and NRTmax (p=0.006) significantly mediated the effect of treatment on the 
outcome 7-day abstinence.  
Table 5. Mediation effects on the 7-day abstinence outcome 





















0.088 0.009 p=0.069 9.2% 
Total QT calls 0.083 0.014 P=0.03 14.3% 
NRT count 0.097 0.000 p=0.987 0% 
NRT max 0.053 0.044 p=0.006 44.9% 
*This is simple mediation analysis 
For the outcome no. of cigarettes per day, the total effect of the treatment was 2.613. The direct 
and the indirect effects of the mediators are represented in table 6. Of the four mediators, total 
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NRTcount (p<0.001) and NRTmax (p<0.001) significantly mediated the effect of treatment on 
the outcome no. of cigarettes per day.  
Table 6. Mediation effects on the no. of cigarettes per day outcome 















2.499 0.113 p=0.097 4.3% 
Total QT calls 2.366 0.248 p=0.07 9.5% 
NRT count 1.366 1.288 p<0.001 50.7% 
NRT max 0.935 1.678 p<0.001 64% 
*This is simple mediation analysis 
The moderation analysis for the outcome no. of cigarettes per day, was conducted by creating an 
interaction term between the treatment and the two moderators and a linear regression was 
performed. The interaction term was not significant for either of the two moderators; baseline 
dependency and craving. The test for fixed effects of treatment by baseline dependency levels 1, 
2, 3 and craving on no. of cigarettes per day, resulted in an insignificant p-values.  For the 
outcome 7-day abstinence, the analysis of maximum likelihood estimates by baseline 
dependency levels 1, 2, 3 and craving, also resulted in insignificant p values.  Below are tables 7 
and 8 showing the parameter estimates and p-values of the moderator analysis on the outcomes 





Table 7. Test of fixed effects of moderators on no. of cigarettes/day. 
Variable Group 
Assignment 
Estimate Pr > |t| 
treatment*baselinedependency1 SBIRT + NRT -1.3152 0.2112 
treatment*baselinedependency2 SBIRT + NRT -1.3563 0.4260 
treatment*baselinedependency3 SBIRT + NRT -2.4195 0.3529 
craving*treatment SBIRT + NRT -0.4014 0.0939 
 
Table 8. Analysis of Maximum Likelihood Estimates of moderators on 7-day abstinence. 
Variable Group 
Assignment 
Estimate Pr > |t| 
treatment*baselinedependency1 SBIRT + NRT -0.0341 0.9449 
treatment*baselinedependency2 SBIRT + NRT -0.4409 0.6041 
treatment*baselinedependency3 SBIRT + NRT 13.3825 0.9801 










Discussion and further implications 
Our study has shown that at the end of a 3 month study period, nicotine replacement therapy 
(NRT) has shown a significant mediation of the intervention on the 7-day abstinence and the no. 
of cigarettes smoked per day. We have also observed that talking to a Quitline counselor has 
shown some marginal mediation of the intervention on the 7-day abstinence and the no. of 
cigarettes smoked per day. Craving and baseline dependency have not shown any moderation 
effect on either of the two outcomes. The absence of moderation may be attributed to the fact 
that the study had a low power to detect a statistical interaction between the moderators and the 
treatment. Our study had a limitation that it was performed at a single site on low-income adult 
population. Despite the fact that patients in this study were diverse with respect to race, ethnicity, 
and gender, it is unclear whether the same results can be replicated in other patient populations. 
So, it is not possible to generalize our results. Basing on these observations, further research 
could be conducted that aim to increase the dosage of the NRT’s to improve the cessation rates. 
Also, further studies can be conducted that can look at whether or not higher Quitline calls to the 
patients on a regular basis improves the smoking cessation rates. Our outcome endpoint was 3 
months. So, it would be interesting to look at the cessation rates over a longer period of time 
(1yr, 2yrs, etc.) with the proposed interventions. Expanding and conducting trials in other patient 
population could be useful to determine if similar interventions would yield the same results in 
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Figure 1: Flow of patients through the trial 
 
  
Assessed for eligibility (n= 29482) 
Randomized (n= 780) 
Standard Care 
Allocated to intervention (n= 390) 
• Received a brochure prepared by 
the state Department of Public 
Health that provides general 
information about smoking 
cessation. 
• Phone number of the toll-free state 
smokers’ quitline
3 Month – Standard Care  (n= 390) 
Deceased (n= 2) 
Lost to follow-up (n= 75) 
  
Intervention (SBIRT + NRT) 
Allocated to intervention (n= 390) 
• 10-15 minute brief motivational 
interview. 
• Six weeks of nicotine replacement 
therapy (NRT) 
•  A referral to the state Smokers’ 
Quitline. 
• Phone call from the nurse three days 
3 Month – SBIRT + NRT  (n= 388) 
Deceased (n= 2) 
Lost to follow-up (n= 70) 
Outcome –  No. of cigs 
per day and 7-day 
abstinence at 3 mo. 
